MATHIAS OELKE
CIK 1921607 · Chief Science Officer · last filed 2023-04-06
MATHIAS OELKE is a Chief Science Officer who has filed 3 SEC Form 4 insider transactions across 1 company since 2022. The most recent filing, for NEXI, was dated Apr 6, 2023. Current disclosed insider exposure totals $13 across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$13
1
3
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| NEXI | Chief Science Officer | 134,023 | $0.00 | $13 | $0 | 3 | 2023-04-06 |
Recent Filings
3 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-04-06 | NEXI | Mixed | — | $0 | EDGAR |
| 2022-11-25 | NEXI | Grant (A) | +126,100 | $0 | EDGAR |
| 2022-04-07 | NEXI | Grant (A) | — | $0 | EDGAR |